Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study

[1] Bommer C(2017)The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study Lancet Diabetes Endocrinol. 5 423-430

[2] Heesemann E(2015)Excess mortality among persons with type 2 diabetes N Engl J Med 373 1720-1732

[3] Sagalova V(2018)Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes N Engl J Med 379 633-644

[4] Manne-Goehler J(1984)The clinical information value of the glycosylated hemoglobin assay N Engl J Med 310 341-346

[5] Atun R(2007)Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group Clin Chem Lab Med 45 1077-1080

[6] Bärnighausen T(2019)6. Glycemic targets: standards of medical care in diabetes-2019 Diabetes Care. 42 S61-S70

[7] Tancredi M(2011)A1C and cardiovascular outcomes in type 2 diabetes: a nested case-control study Diabetes Care 34 77-83

[8] Rosengren A(2014)Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention Circ Cardiovasc Interv. 7 503-509

[9] Svensson AM(2015)Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus Circ Heart Fail. 8 236-242

[10] Kosiborod M(2011)Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study Arch Intern Med 171 1920-1927

[1] Bommer C(2017)The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study Lancet Diabetes Endocrinol. 5 423-430

[2] Heesemann E(2015)Excess mortality among persons with type 2 diabetes N Engl J Med 373 1720-1732

[3] Sagalova V(2018)Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes N Engl J Med 379 633-644

[4] Manne-Goehler J(1984)The clinical information value of the glycosylated hemoglobin assay N Engl J Med 310 341-346

[5] Atun R(2007)Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group Clin Chem Lab Med 45 1077-1080

[6] Bärnighausen T(2019)6. Glycemic targets: standards of medical care in diabetes-2019 Diabetes Care. 42 S61-S70

[7] Tancredi M(2011)A1C and cardiovascular outcomes in type 2 diabetes: a nested case-control study Diabetes Care 34 77-83

[8] Rosengren A(2014)Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention Circ Cardiovasc Interv. 7 503-509

[9] Svensson AM(2015)Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus Circ Heart Fail. 8 236-242

[10] Kosiborod M(2011)Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study Arch Intern Med 171 1920-1927